
Jonathan L Carter MD
Neuroimmunology/Multiple Sclerosis, Neurophysiology
Associate Professor, Neurology, Mayo Medical School
Join to view full profile
13400 E Shea BlvdScottsdale, AZ 85259
Phone+1 480-301-8000
Dr. Carter is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 1982 - 1985
Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 1981 - 1982
Mayo Clinic College of MedicineClass of 1981
Certifications & Licensure
NH State Medical License 2015 - Present
AZ State Medical License 1986 - 2028
NV State Medical License 2015 - 2017
VT State Medical License 2014 - 2016
MN State Medical License 1987 - 1998
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification PowerChart (CQM), Cerner Corporation, 2014-2017
- CMS Meaningful Use Stage 1 Certification HealthSentry, Cerner Corporation, 2014-2017
- CMS Meaningful Use Stage 2 Certification FirstNet (Clinical), Cerner Corporation, 2014-2017
Clinical Trials
- Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis Start of enrollment: 2005 Apr 01
- Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) Start of enrollment: 2016 Dec 01
Publications & Presentations
PubMed
- 25 citationsCerebral enhancement in MOG antibody-associated disease.Paul Elsbernd, Laura Cacciaguerra, Karl N Krecke, John J Chen, David Gritsch
Journal of Neurology, Neurosurgery, and Psychiatry. 2023-12-14 - 2 citationsRetinal Vasculopathy With Cerebral Leukoencephalopathy and Systemic Manifestations: Critical Role of Retina Specialists.Odette M Houghton, Jonathan Carter, Radhika Dhamija
Journal of Vitreoretinal Diseases. 2022-12-03 - 4 citationsUsing Monoclonal Antibody Therapies for Multiple Sclerosis: A Review.Paul M. Elsbernd, Jonathan L. Carter
Biologics. 2021-06-30
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









